Måndag 5 Maj | 10:15:44 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2020-02-12 - X-dag kvartalsutdelning ORI 4.3126
2019-11-14 - X-dag kvartalsutdelning ORI 4.3126
2019-11-07 - Kvartalsrapport 2019-Q3
2019-09-30 - Extra Bolagsstämma 2019
2019-08-14 - X-dag kvartalsutdelning ORI 4.3126
2019-08-08 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag kvartalsutdelning ORI 4.3126
2019-05-09 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-14 - X-dag kvartalsutdelning ORI 4.1922
2019-02-14 - Bokslutskommuniké 2018
2018-11-14 - X-dag kvartalsutdelning ORI 4.1004
2018-11-07 - Kvartalsrapport 2018-Q3
2018-08-14 - X-dag kvartalsutdelning ORI 4.174
2018-08-07 - Kvartalsrapport 2018-Q2
2018-05-08 - X-dag kvartalsutdelning ORI 14.7594
2018-05-04 - Årsstämma
2018-05-04 - Kvartalsrapport 2018-Q1
2018-02-15 - Bokslutskommuniké 2017
2018-02-14 - X-dag kvartalsutdelning ORI 2.47
2017-11-14 - X-dag kvartalsutdelning ORI 2.4392
2017-11-08 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2
2017-08-14 - X-dag kvartalsutdelning ORI 2.395
2017-05-12 - X-dag kvartalsutdelning ORI 7.2357
2017-05-10 - Kvartalsrapport 2017-Q1
2017-05-09 - Årsstämma
2017-02-16 - Kapitalmarknadsdag 2017
2017-02-16 - Bokslutskommuniké 2016
2017-02-14 - X-dag kvartalsutdelning ORI 2.4363
2016-11-14 - X-dag kvartalsutdelning ORI 1.9791
2016-11-11 - Kvartalsrapport 2016-Q3
2016-08-16 - Kvartalsrapport 2016-Q2
2016-05-18 - X-dag kvartalsutdelning ORI 0
2016-05-18 - Kvartalsrapport 2016-Q1
2016-05-17 - Årsstämma
2016-05-17 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-12 - Kvartalsrapport 2015-Q3
2015-08-13 - Kvartalsrapport 2015-Q2
2015-05-20 - X-dag kvartalsutdelning ORI 0
2015-05-19 - Årsstämma
2015-05-08 - Kvartalsrapport 2015-Q1
2015-02-11 - Bokslutskommuniké 2014
2014-11-04 - Analytiker möte 2014
2014-11-04 - Kvartalsrapport 2014-Q3
2014-08-14 - Kvartalsrapport 2014-Q2
2014-05-20 - X-dag kvartalsutdelning ORI 2.2533
2014-05-19 - Extra Bolagsstämma 2014
2014-05-19 - Årsstämma
2014-05-07 - Kvartalsrapport 2014-Q1
2014-02-14 - Bokslutskommuniké 2013
2013-11-12 - Analytiker möte 2013
2013-11-12 - Kvartalsrapport 2013-Q3
2013-08-15 - Kvartalsrapport 2013-Q2
2013-05-22 - X-dag ordinarie utdelning ORI 15.05 SEK
2013-05-21 - Extra Bolagsstämma 2013
2013-05-21 - Årsstämma
2013-04-25 - Kvartalsrapport 2013-Q1
2013-02-14 - Bokslutskommuniké 2012
2012-12-19 - Extra Bolagsstämma 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-08-14 - Kvartalsrapport 2012-Q2
2012-05-22 - X-dag ordinarie utdelning ORI 15.77 SEK
2012-05-21 - Årsstämma
2012-04-27 - Kvartalsrapport 2012-Q1
2012-02-17 - Bokslutskommuniké 2011
2011-11-10 - Kvartalsrapport 2011-Q3
2011-08-10 - Kvartalsrapport 2011-Q2
2011-05-20 - X-dag ordinarie utdelning ORI 13.08 SEK
2011-05-19 - Extra Bolagsstämma 2011
2011-05-19 - Årsstämma
2011-05-04 - Kvartalsrapport 2011-Q1
2011-02-16 - Bokslutskommuniké 2010
2010-10-26 - Kvartalsrapport 2010-Q3
2010-08-11 - Kvartalsrapport 2010-Q2
2010-05-20 - X-dag ordinarie utdelning ORI 12.80 SEK
2010-05-19 - Årsstämma
2010-04-21 - Kvartalsrapport 2010-Q1
2010-02-10 - Bokslutskommuniké 2009
2009-10-23 - Kvartalsrapport 2009-Q3
2009-08-12 - Kvartalsrapport 2009-Q2
2009-05-20 - X-dag ordinarie utdelning ORI 13.65 SEK
2009-05-19 - Årsstämma
2009-04-23 - Kvartalsrapport 2009-Q1

Beskrivning

LandSchweiz
SektorHandel & varor
IndustriDetaljhandel
Oriflame är ett internationellt, direktförsäljande kosmetikföretag grundat i Sverige 1967. Bolaget bedriver egen forskning och utveckling och har ett produktutbud av svenska skönhetsprodukter inspirerade av naturen. Detta inkluderar hudvård, nutrition, make-up, parfymer och hårvård. Oriflame marknadsförs via oberoende Oriflame-konsulter och är en schweizisk bolagskoncern noterad på Nasdaq Stockholm.
2019-05-09 07:15:00
Important information concerning IFRS
  • Oriflame has implemented IFRS 15 Revenue from Contracts with Customers from 1st January 2018. Early adoption of IFRS 16 Leases has been carried out to allow all changes to be implemented at the same time.
  • Unless otherwise stated, comparisons and comments on the numbers are now prepared according to the implemented IFRS 15 and IFRS 16.
Three months ended 31 March 2019
  • Local currency sales decreased by 6% and Euro sales decreased by 7% to €309.2m (€330.8m), of which 2 percentage points are related to a one-off IFRS effect.
  • Number of registered actives decreased by 5% and amounted to 2.9m.
  • Operating margin was 10.5% (10.5%), negatively impacted by 30 bps from currencies, and operating profit was €32.5m (€34.8m).
  • Net profit was €23.0m (€21.0m) and diluted EPS €0.40 (€0.36).
  • Cash flow from operating activities was €20.5m (€24.9m).
  • The year to date sales development is approximately -5% in local currency and the development in the second quarter to date is approximately -4% in local currency.

CEO Magnus Brännström comments

"Despite a weaker sales development and changed geographical mix, we are pleased to report a stable profitability for the quarter and continued healthy cash flow generation. While we are encouraged by the positive development in Latin America, Africa, Europe and most of the CIS markets, we continued to see a sales decline in Asia & Turkey impacted by challenging market conditions as well as governmental and legislative initiatives in China and Vietnam. The sales development during the second quarter to date reflects the performance in the first quarter. Oriflame has a balanced geographical footprint, and we will continue to take responsible steps adapted to each respective market to drive sales and healthy margins."

Other
A Swedish translation is available on www.oriflame.com.

Conference call for the financial community
The Company will host a conference call on Thursday, 9 May 2019 at 9.30 CET.

Participant access numbers:
Denmark: +4582333194
Finland: +358981710520
Sweden: +46856642695
United Kingdom: +443333009267
United States: +18335268382
Norway: +47 23500243 (PIN: 40940005#)
The conference call will also be audioweb cast in "listen-only" mode through Oriflame's website: www.oriflame.com or through http://oriflame-ir.creo.se/190509
This report has not been audited by the Company's auditors.
May 9, 2019
Magnus Brännström
Chief Executive Officer

For further information, please contact:      
Magnus Brännström, Chief Executive Officer   Tel: +41 798 263 754
Gabriel Bennet, Chief Financial Officer    Tel: +41 798 263 769
Nathalie Redmo, Sr. Manager IR     Tel: +41 799 220 173

This is information that Oriflame Holding AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:15 CET on May 9, 2019.

Oriflame Holding AG
Bleicheplatz 3, CH-8200 Schaffhausen, Switzerland
www.oriflame.com
Company registration no CHE-134.446.883